Coldstream Capital Management’s Allergan plc AGN Stock Holding History

Coldstream Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,167	Closed	-$207K	–	338
2020 Q1	$207K	Buy	1,167 +15	+1%	+$2.82K	0.02%	257
2019 Q4	$220K	Buy	+1,152	New	+$208K	0.02%	313
2018 Q4	–	Sell	-1,492	Closed	-$285K	–	406
2018 Q3	$285K	Buy	1,492 +175	+13%	+$32.1K	0.03%	274
2018 Q2	$219K	Buy	+1,317	New	+$211K	0.02%	299
2017 Q4	–	Sell	-1,002	Closed	-$205K	–	327
2017 Q3	$205K	Buy	+1,002	New	+$233K	0.02%	294

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Coldstream Capital Management's AGN Position: Q2 2020 in Review

Coldstream Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,167 shares — an estimated $207K sold.

Coldstream Capital Management first reported a position in AGN in Q3 2017 and held it in 5 quarters. The position peaked at $285K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Coldstream Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Coldstream Capital Management sold 1,167 Allergan plc shares in Q2 2020, an estimated $207K.
Coldstream Capital Management first reported a position in Allergan plc in Q3 2017 and held it in 5 quarters.
Coldstream Capital Management's Allergan plc position peaked at $285K in Q3 2018.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Coldstream Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.